Regeneron Pharmaceuticals (REGN) Net Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 6,620.00 |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | -13,815.00 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 7,793.00 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 9,934.00 |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | -5,319.00 |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 31,387.00 |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | 1,366.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -44.00 |
| Mar 31, 2026 | -569.00 |
| Dec 31, 2025 | -117,536.00 |
| Sep 30, 2025 | -592.00 |
| Jun 30, 2025 | 804.00 |
| Mar 31, 2025 | -613.00 |
| Dec 31, 2024 | -2,080.00 |
| Sep 30, 2024 | -1,124.00 |
| Jun 30, 2024 | -1,993.00 |
| Mar 31, 2024 | -2,114.00 |
| Dec 31, 2023 | -1,367.00 |
| Sep 30, 2023 | -674.00 |
| Jun 30, 2023 | -1,530.00 |
| Mar 31, 2023 | -830.00 |
| Dec 31, 2022 | 115,460.00 |
| Sep 30, 2022 | 641.00 |
| Jun 30, 2022 | 1,758.00 |
| Mar 31, 2022 | -76.00 |
| Dec 31, 2021 | 246.00 |
| Sep 30, 2021 | 1,152.00 |